The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...
The approval introduces the therapy ... In January, 2025, J&J’s nasal spray Spravato secured a label expansion from the FDA for use as a single agent in adults with major depressive disorder ...
Tesla and SpaceX CEO Elon Musk clarified that he uses only "a small amount once every other week or something like that" ...
only approves the drug ketamine for use in general anesthetics. However, Medicare may cover the drug Spravato, which contains esketamine. This is an FDA-approved drug that derives from ...
4don MSN
In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...
The FDA approved oral iptacopan (Fabhalta; Novartis) to reduce proteinuria in adults with C3 glomerulopathy (C3G), according ...
The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback